gdc

Breast Cancer

Articles and resources on breast cancer for patients, caregivers, and family members
Pink Ribbons in October
Breast Cancer
Welcome to our newest issue of CONQUER. We know the value of hearing the experiences of cancer survivors and family caregivers. It helps people to relate, feel a sense of connection, and provides food for thought. We have many stories, with several focusing on breast cancer, including male breast cancer. Pink ribbons are not just for women.
Listening to Our Instincts
Breast CancerSurvivorship
Cancer was the furthest thing from my mind, for many reasons. There was absolutely no family history of cancer. I was an avid fitness enthusiast. I tried to eat healthy, and the list goes on. And perhaps the most important reason for my peace of mind, a few months before my diagnosis, a mammogram and a follow-up appointment with my gynecologist gave me the “all clear” reassurance. Despite continued pain in my left breast, and sensitivity in the nipple, I was grateful that nothing was found.
The Good, the Bad, and the Funny: Making the Most of a Life Shaped by Breast Cancer
Breast CancerPatient Stories
Enjoy Lillie Shockney’s sense of humor as you read her personal story of how working as a nurse and facing her own breast cancer diagnosis shaped her life and her lifelong work as a breast cancer educator and advocate.
A Breakthrough in the Treatment of Metastatic Triple-Negative Breast Cancer
Breast CancerImmunotherapy
Recently, Tecentriq became the first immunotherapy to be approved for the treatment of patients with metastatic triple-negative breast cancer, a particularly difficult type of breast cancer.
Keytruda plus Chemotherapy in Triple-Negative Breast Cancer
Breast CancerImmunotherapy
Triple-negative breast cancer is an aggressive type of cancer that usually has a high rate of disease recurrence (returning) within the first 5 years after diagnosis.
Piqray New Treatment Approved for Metastatic Breast Cancer and PI3KCA Mutation
Breast CancerFDA Approvals, News & Updates
In May 2019, the FDA approved Piqray (alpelisib), the first PI3K inhibitor for the treatment of metastatic breast cancer with a PI3KCA mutation in postmenopausal women, and in men. An FDA spokesperson said it was the first treatment “to demonstrate a clinically meaningful benefit” for this type of breast cancer.
FDA Calls Attention to Risk Associated with Breast Implants: Anaplastic Large-Cell Lymphoma
Breast CancerLymphomaSurvivorship
In February 2019, the FDA issued a letter to raise awareness of the risk for a rare type of lymphoma, BIA-ALCL, that is linked to all types of breast implants. Although this is an uncommon reaction to implants, all women who have or intend to get an implant after breast cancer should be aware of this risk. Learn more about this risk here.
My Family's Love is the Reason I Fight
Breast CancerSurvivorshipWeb Exclusives
Melody recounts her story of being a 34-year-old new mother diagnosed with breast cancer.
Page 1 of 8
Results 1 - 10 of 75

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country